Prime medicine to participate in upcoming investor conferences

Cambridge, mass., may 29, 2025 (globe newswire) -- prime medicine, inc. (nasdaq: prme), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that company management will participate in the following upcoming conferences: jefferies global healthcare conference: fireside chat on thursday, june 5, 2025, at 10:30 a.m.

PRME Ratings Summary

PRME Quant Ranking